0001062993-22-015292.txt : 20220621 0001062993-22-015292.hdr.sgml : 20220621 20220621194942 ACCESSION NUMBER: 0001062993-22-015292 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220617 FILED AS OF DATE: 20220621 DATE AS OF CHANGE: 20220621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DICICCO WENDY F CENTRAL INDEX KEY: 0001225165 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39271 FILM NUMBER: 221029606 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Renovacor, Inc. CENTRAL INDEX KEY: 0001799850 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 BROADWAY STREET 2: SUITE 310 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 610-424-2650 MAIL ADDRESS: STREET 1: 201 BROADWAY STREET 2: SUITE 310 CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Chardan Healthcare Acquisition 2 Corp. DATE OF NAME CHANGE: 20200306 FORMER COMPANY: FORMER CONFORMED NAME: Chardan Healthcare Acquisition III Corp. DATE OF NAME CHANGE: 20200113 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2022-06-17 0001799850 Renovacor, Inc. RCOR 0001225165 DICICCO WENDY F C/O RENOVACOR, INC. 201 BROADWAY, SUITE 310 CAMBRIDGE MA 02139 0 1 0 0 Chief Financial Officer Stock Option 1.80 2022-06-17 4 A 0 155325 0 A 2032-06-17 Common Stock 155325 155325 D The stock option will vest and become exercisable in full on June 17, 2026, with 25% vesting on June 17, 2023, and the remainder vesting in equal monthly installments for the remaining 36 months, subject to the continuous service of the Reporting Person on such vesting dates. /s/ Joseph Carroll, as attorney-in-fact 2022-06-21